Light of DNA-alkylating agents in castration-resistant prostate cancer cells: a novel mixed EGFR/DNA targeting combi-molecule.

about

Light of DNA-alkylating agents in castration-resistant prostate cancer cells: a novel mixed EGFR/DNA targeting combi-molecule.

Item

http://www.wikidata.org/entity/Q41364214

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Light of DNA-alkylating agents ...... /DNA targeting combi-molecule.

@en

type

Item

label

Light of DNA-alkylating agents ...... /DNA targeting combi-molecule.

@en

prefLabel

Light of DNA-alkylating agents ...... /DNA targeting combi-molecule.

@en

P1476

Light of DNA-alkylating agents ...... /DNA targeting combi-molecule.

@en

P2093

Guan-Can Liang

http://www.w3.org/2001/XMLSchema#string

Hao-Feng Zheng

http://www.w3.org/2001/XMLSchema#string

Teng-Cheng Li

http://www.w3.org/2001/XMLSchema#string

Wei Liu

http://www.w3.org/2001/XMLSchema#string

Yan-Xiong Chen

http://www.w3.org/2001/XMLSchema#string

You-Qiang Fang

http://www.w3.org/2001/XMLSchema#string

P2860

BRAT1 deficiency causes increased glucose metabolism and mitochondrial malfunction

Nedd4 family interacting protein 1 (Ndfip1) is required for ubiquitination and nuclear trafficking of BRCA1-associated ATM activator 1 (BRAT1) during the DNA damage response

Tim/Timeless, a member of the replication fork protection complex, operates with the Warsaw breakage syndrome DNA helicase DDX11 in the same fork recovery pathway

Cancer statistics, 2016

Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer.

Biological effects of novel "combi-targeting" molecule and its effect on DNA repair pathway in hormone-refractory prostate cancer

Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines.

Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication.

Targeting hexokinase 2 in castration-resistant prostate cancer

Co-targeting hexokinase 2-mediated Warburg effect and ULK1-dependent autophagy suppresses tumor growth of PTEN- and TP53-deficiency-driven castration-resistant prostate cancer.

P304

3245-3257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28804543

http://www.w3.org/2001/XMLSchema#string

P932

5553875

http://www.w3.org/2001/XMLSchema#string